Abstract
In the preceding chapters it was shown that, based upon electrophysiological principles, arrhythmias can be classified according to mechanisms, and antiarrhythmic agents also can be grouped into several classes and subclasses (see Chaps. 4, 2). In the present chapter, I will describe the electrophysiological basis for subclassification of sodium channel blocking (class I) antiarrhythmic agents and review current models for their mechanism of action. Interactions of multiple agents with a common receptor and clinical implications will be emphasized. Although the chapter will be limited to the sodium channel receptor, it should be noted that these principles can be applied equally well to other classes of antiarrhythmic agents (Hondeghem and Katzung 1984; Roden et al. 1986).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aldrich RW, Corey DP, Stevens CF (1983) A reinterpretation of mammalian sodium channel gating based on single channel recording. Nature 306: 436–441
Anderson JL (1985) Rationale of combination antiarrhythmic drug therapy. Cardiovasc Clin 16 (l): 307–327
Bassett AL, Bigger JT, Hoffman BF (1970) Protective action of diphenylhydantoin on canine Purkinje fibers during hypoxia. J Pharmacol Exp Ther 173: 336–343
Bean BP, Cohen CJ, Tsien RW (1983) Lidocaine block of cardiac sodium channels. J Gen Physiol 81: 613–642
Bennett PB, Stroobandt R, Kesteloot H, Hondeghem LM (1987a) Sodium channel block by a potent, new antiarrhythmic agent, transcainide, in guinea pig ventricular myocytes. J Cardiovasc Pharmacol 9: 661–667
Bennett PB, Woosley RL, Hondeghem LM (1987b) Competition between lidocaine and one of its metabolites, glycylxylidide, for cardiac sodium channels. Circulation in press
Bigger JT, Mandel WJ (1970) Effect of lidocaine on conduction in canine Purkinje fibers and at the ventricular muscle-Purkinje fiber junction. J Pharmacol Exp Ther 172: 239–254
Breithardt G, Seipel L, Abendroth RR (1981) Comparison of antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia. J Cardiovasc Pharmacol 3: 1026–1037
Broughton A, Grant AO, Starmer CF, Klinger JK, Stambler BS, Strauss HC (1984) Lipid solubility modulates pH potentiation of local anesthetic block of Kmax reactivation in guinea pig myocardium. Circ Res 55: 513–523
Cahalan MD (1978) Local anesthetic block of sodium channels in normal and pronase-treated squid giant axons. Biophys J 23: 285–311
Chen C, Gettes LS, Katzung BG (1975) Effects of lidocaine and quinidine on steady- state characteristics and recovery kinetics of (dK/dOmax in guinea pig ventricular myocardium. Circ Res 37: 20–29
Clarkson CW, Matsubara T, Hondeghem LM (1984) Slow inactivation of Fmax in guinea pig ventricular myocardium. Am J Physiol 27: 645–654
Clarkson CW, Hondeghem LM (1985 a) Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology 62: 396–405
Clarkson CW, Hondeghem LM (1985b) Evidence for a specific receptor site for lidocaine, quinidine, and bupivacaine associated with cardiac sodium channels in guinea pig ventricular myocardium. Circ Res 56: 496–506
Clarkson CW, Follmer CH, Yeh JZ, Ten Eick RE, Hondeghem LM (1985) Evidence for two components of sodium channel block by lidocaine in single isolated cardiac myocytes. Circulation 72 (Suppl III): 38
Courtney KR (1975) Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA 968. J Pharmacol Exp Ther 195: 225–236
Courtney KR (1983) Quantifying antiarrhythmic drug blocking during action potentials in guinea-pig papillary muscle. J Mol Cell Cardiol 15: 749–757
Duff HJ, Roden D, Primm RK, Oates JA, Woosley RL (1983) Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine. Circulation 67: 1124–1128
Ehring GR, Moyer JW, Hondeghem LM (1987) Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives. J Pharmacol Exp Ther (to be published )
Elharrar V, Zipes DP (1982) Effects of encainide and metabolites (MJ14030 and MJ9444) on canine cardiac Purkinje and ventricular fibers. J Pharmacol Exp Ther 220: 460–447
Gintant GA, Hoffman BF (1984) Use-dependent block of cardiac sodium channels by quaternary derivatives of lidocaine. Pflugers Arch 400: 121–129
Grant AO, Strauss LJ, Wallace AG, Strauss HC (1980) The influence of pH on the electrophysiological effects of lidocaine in guinea pig ventricular myocardium. Circ Res 47: 542–550
Grant AO, Starmer CF, Strauss HC (1983) Unitary sodium channels in isolated card-iac myocytes of rabbit. Circ Res 53: 823–829
Handel F, Luzzi FA, Wenger TL, Barchowsky A, Shand DG, Strauss H (1983) Lido- caine and its metabolites in canine plasma and myocardium. J Cardiovasc Pharmacol 5: 44–50
Hill JL, Gettes LS (1980) Effect of acute coronary occlusion on local myocardial extracellular K+ activity in swine. Circulation 61: 768–778
Hille B (1977) Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69: 497–515
Hodgkin AL, Huxley AF (1952) A quantiative description of membrane current and its application to conduction and excitation in nerve. J Physiol (Lond) 117: 500–544
Hoffman BF, Bigger JT (1971) Antiarrhythmic drugs. In: DiPalma J (ed) Drills pharmacology in medicine, 4th edn. McGraw-Hill, New York p 824 Hondeghem LM (1987) Antiarrhythmic agents: modulated receptor applications. Circulation 75: 514–520
Hondeghem LM, Katzung BG (1977) Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 472: 373–398
Hondeghem LM, Katzung BG (1980) Test of a model antiarrhythmic drug action: ef-fects of quinidine and lidocaine on myocardial conduction. Circulation 61: 1217–1224
Hondeghem LM, Katzung BG (1984) Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel blocking drugs. Annu Rev Pharmacol Toxicol 24: 386–423
Hondeghem LM, Matsubara T (1984) Quinidine and lidocaine: activation and inactivation block. Proc West Pharmacol Soc 27: 19–21
Hondeghem LM, Grant AO, Jensen RA (1974) Antiarrhythmic drug action: selective depression of hypoxic cardiac cells. Am Heart J 87: 602–605
Hondeghem LM, Matsubara T (1988) Quinidine blocks cardiac sodium channels during opening and slow inactivation in guinea-pig papillary muscle. Br J Pharmacol 93: 311–318
Hope RR, Williams DO, El-Sherif N, Lazzara R, Scherlag BJ (1974) The efficacy of antiarrhythmic agents during acute myocardial ischemia and the role of heart rate. Circulation 50: 507–514
Jensen R, Katzung B (1970) Electrophysiological actions of diphenylhydantoin on rabbit atria. Circ Res 26: 17–27
Johnson EA, McKinnon MG (1957) The differential effect of quinidine and pyrila- mine on the myocardial action potential at various rates of stimulation. J Pharmacol Exp Ther 120: 460–468
Kohlhardt M, Seifert C (1985) Properties of Kmax block of Ina-mediated action poten-tials during combined application of antiarrhythmic drugs in cardiac muscle. Nau- nyn Schmiedeberg’s Arch Pharmacol 330: 235–244
Kunze DL, Lacerda AE, Wilson DL, Brown AM (1985) Cardiac Na currents and the inactivating, reopening, and waiting properties of single cardiac Na channels. J Gen Physiol 86: 691–719
Mason JW, Hondeghem LM, Katzung BG (1984) Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res 55: 277–285
Matsubara T, Clarkson C, Hondeghem L (1987) Lidocaine blocks open and inactivated cardiac sodium channels. Naunyn Schmiedeberg’s Arch Pharmacol 336: 224–231
Moorman JR, Yee R, Bjornsson T, Starmer CF, Grant AO, Strauss HC (1986) pdoes not predict pH potentiation of sodium channel blockade by lidocaine and W6211 in guinea pig ventricular myocardium. J Pharmacol Exp Ther 238: 159–166
Moyer JW (1985) The interaction of a series of aprindine derivatives with cardiac sodium channels. Dissertation, University of California, San Francisco
Nishimura M, Follmer CH, Cigan AL, Yah JZ (1986) Amiodarone blocks Ca++ current in guinea pig ventricular myocytes. Circulation 74 (Suppl II): 169
Nokin P, Clinet M, Swillens S, Delisee C, Meysmans L, Chatelain P (1986) Allosteric modulation of [3H] nitrendipine binding to cardiac and cerebral cortex membranes by amiodarone. J Cardiovasc Pharmacol 8: 1051–1057
Polster P, Broekhuysen J (1976) The adrenergic antagonism of amiodarone. Biochem Pharmacol 25: 131–134
Roden DM, Bennett PB, Hondeghem LM (1986) Quinidine blocks cardiac potassium channels in a time- and voltage-dependent fashion. Biophys J 49: 352a
Sada H, Kojima M, Ban T (1979) Effect of procainamide on transmembrane action potentials in guinea-pig papillary muscles as affected by external potassium concentration. Arch Pharmacol 309: 179–190
Saikawa T, Carmeliet E (1982) Slow recovery of the maximal rate of rise ( Fmax) of the action potential in sheep cardiac Purkinje fibers. Pflugers Arch 394: 90–93
Sanchez-Chapula J (1985) Electrophysiological interactions between quinidine-lido- caine and quinidine-phenytoin in guinea-pig papillary muscle. Naunyn Schmiede- berg’s Arch Pharmacol 331: 369–375
Sanchez-Chapula J, Tsuda Y, Josephson IR (1983) Voltage- and use-dependent effects of lidocaine on sodium current in rat single ventricular cells. Circ Res 52: 557–565
Singh BN, Vaughan Williams EM (1970) The effect of amiodarone, a new antianginal drug, on cardiac muscle. Br J Pharmacol 39: 657–667
Singh BN, Vaughan Williams EM (1971) Effect of altering potassium concentration on the action of lidocaine and diphenylhydantoin on rabbit atrial and ventricular muscle. Circ Res 24: 286–295
Snyders DJ, Hondeghem LM (1987) Drug-associated channels inactivate and reactivate at more negative potentials than drug-free channels. Proc West Pharmacol Soc 30 (in Press): 149–151
Starmer CF, Courtney KR (1986) Modelling ion channel blockade at guarded binding sites: application to tertiary drugs. Am J Physiol 251: H848–856
Starmer CF, Grant AO, Strauss HC (1983) A model of the interaction of local anesthetics with Na channels. Biophys J 41: 145a
Starmer CF, Grant AO, Strauss HC (1984) Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophys J 46: 15–27
Strichartz GR (1973) The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine. J Gen Physiol 62: 37–57
Vaughan Williams EM (1970) Classification of anti-arrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Olesen KH (eds) Symposium on cardiac Arrhythmias. Astra, Elsinore, Denmark, pp 449–501
Weidmann S (1955) Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibers. J Physiol (Lond) 129: 568–582
Weld FM, Coromilas J, Rottman JN, Bigger JT (1982) Mechanisms of quinidine-in- duced depression of maximum upstroke velocity in ovine cardiac Purkinje fibers. Circ Res 50: 369–376
Yeh JZ, Narahashi T (1977) Kinetic analysis of pancuronium interaction with sodium channels in squid axon membranes. J Gen Physiol 69: 2293–2323
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hondeghem, L.M. (1989). Interaction of Class I Drugs with the Cardiac Sodium Channel. In: Vaughan Williams, E.M. (eds) Antiarrhythmic Drugs. Handbook of Experimental Pharmacology, vol 89. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73666-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-73666-7_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73668-1
Online ISBN: 978-3-642-73666-7
eBook Packages: Springer Book Archive